詞庫查詢
查詢 Elsevier TF-IDF 關鍵詞（16,935 詞）與 THU 中文擴充詞庫。想知道自己的研究會命中哪些規則？先查這裡。
Elsevier TF-IDF 詞 16,935 筆
| SDG | 目標 | 詞 | 集合內文獻 | Scopus 文獻 | 佔比 | TF-IDF |
|---|---|---|---|---|---|---|
| 3 | 良好健康與福祉 | ascvd |
2,642 | 2,853 | 93% | 19.26 |
| 3 | 良好健康與福祉 | chronic kidney disease patient |
3,079 | 3,310 | 93% | 19.26 |
| 3 | 良好健康與福祉 | cvd mortality |
2,738 | 2,955 | 93% | 19.26 |
| 3 | 良好健康與福祉 | thrombolysis in cerebral infarction |
1,220 | 1,252 | 97% | 19.26 |
| 3 | 良好健康與福祉 | prostate cancer radiotherapy |
1,686 | 1,796 | 94% | 19.26 |
| 3 | 良好健康與福祉 | preoperative chemoradiotherapy |
1,646 | 1,750 | 94% | 19.26 |
| 3 | 良好健康與福祉 | enzalutamid |
2,573 | 2,780 | 93% | 19.26 |
| 3 | 良好健康與福祉 | adolescent obesity |
1,566 | 1,658 | 94% | 19.26 |
| 3 | 良好健康與福祉 | trastuzumab. |
2,298 | 2,483 | 93% | 19.26 |
| 3 | 良好健康與福祉 | latent tb |
2,374 | 2,566 | 93% | 19.26 |
| 3 | 良好健康與福祉 | response to neoadjuvant chemotherapy |
1,974 | 2,124 | 93% | 19.26 |
| 3 | 良好健康與福祉 | orthotopic xenograft |
1,835 | 1,967 | 93% | 19.26 |
| 3 | 良好健康與福祉 | hba 1c |
2,136 | 2,305 | 93% | 19.26 |
| 3 | 良好健康與福祉 | hmlh1 |
1,734 | 1,852 | 94% | 19.26 |
| 3 | 良好健康與福祉 | anticancer compound |
2,425 | 2,622 | 92% | 19.26 |
| 3 | 良好健康與福祉 | cancer outcomes |
4,361 | 4,571 | 95% | 19.26 |
| 3 | 良好健康與福祉 | direct-acting antiviral agent |
1,352 | 1,409 | 96% | 19.26 |
| 3 | 良好健康與福祉 | pre-diabetes |
2,457 | 2,658 | 92% | 19.26 |
| 3 | 良好健康與福祉 | atezolizumab |
2,286 | 2,472 | 92% | 19.26 |
| 3 | 良好健康與福祉 | obesity paradox |
1,349 | 1,406 | 96% | 19.26 |
| 3 | 良好健康與福祉 | cancer targeted therapy |
1,309 | 1,359 | 96% | 19.26 |
| 3 | 良好健康與福祉 | international study of asthma and allergies in childhood |
1,136 | 1,154 | 98% | 19.26 |
| 3 | 良好健康與福祉 | obesity and type 2 diabetes |
4,355 | 4,568 | 95% | 19.26 |
| 3 | 良好健康與福祉 | 1247 1286 19.260601 97 epidermal growth factor receptor-2 |
1,584 | 1,681 | 94% | 19.26 |
| 3 | 良好健康與福祉 | receptor tyrosine kinase inhibitors |
1,565 | 1,659 | 94% | 19.26 |
| 3 | 良好健康與福祉 | anti-cancer activities |
1,783 | 1,910 | 93% | 19.26 |
| 3 | 良好健康與福祉 | cancer cost |
1,707 | 1,823 | 94% | 19.26 |
| 3 | 良好健康與福祉 | shiga toxin-producing |
3,235 | 3,475 | 93% | 19.26 |
| 3 | 良好健康與福祉 | sentinel lymph nodes |
3,535 | 3,777 | 94% | 19.26 |
| 3 | 良好健康與福祉 | overweight or obesity |
4,053 | 4,283 | 95% | 19.26 |
| 3 | 良好健康與福祉 | allergy asthma |
2,789 | 3,014 | 93% | 19.26 |
| 3 | 良好健康與福祉 | b16f10 melanoma |
1,829 | 1,963 | 93% | 19.26 |
| 3 | 良好健康與福祉 | braf inhibitor |
2,376 | 2,572 | 92% | 19.26 |
| 3 | 良好健康與福祉 | nnrtis |
2,108 | 2,277 | 93% | 19.26 |
| 3 | 良好健康與福祉 | post-stroke patient |
1,800 | 1,930 | 93% | 19.26 |
| 3 | 良好健康與福祉 | linkage to care |
1,636 | 1,742 | 94% | 19.26 |
| 3 | 良好健康與福祉 | circumferential resection margin |
1,243 | 1,282 | 97% | 19.26 |
| 3 | 良好健康與福祉 | myocardial infarction |
2,158 | 2,333 | 92% | 19.26 |
| 3 | 良好健康與福祉 | t790m mutation |
1,421 | 1,492 | 95% | 19.26 |
| 3 | 良好健康與福祉 | chronic hiv |
1,718 | 1,837 | 94% | 19.26 |
| 3 | 良好健康與福祉 | hnscc cells |
1,295 | 1,344 | 96% | 19.26 |
| 3 | 良好健康與福祉 | five-year overall survival |
1,963 | 2,116 | 93% | 19.26 |
| 3 | 良好健康與福祉 | integrase inhibitors |
1,547 | 1,640 | 94% | 19.26 |
| 3 | 良好健康與福祉 | sh-sy5y neuroblastoma cell |
1,754 | 1,879 | 93% | 19.26 |
| 3 | 良好健康與福祉 | peginterferon |
2,739 | 2,964 | 92% | 19.26 |
| 3 | 良好健康與福祉 | tobacco dependence |
2,162 | 2,339 | 92% | 19.26 |
| 3 | 良好健康與福祉 | breast cancer mcf-7 cells |
1,392 | 1,459 | 95% | 19.26 |
| 3 | 良好健康與福祉 | stroke care |
3,830 | 4,072 | 94% | 19.26 |
| 3 | 良好健康與福祉 | a/h1n1 |
1,933 | 2,083 | 93% | 19.26 |
| 3 | 良好健康與福祉 | neoplasm staging |
1,751 | 1,876 | 93% | 19.26 |